{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:53:30Z","timestamp":1780523610017,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente"],"award-info":[{"award-number":["Ricerca corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["line 3d"],"award-info":[{"award-number":["line 3d"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["to INMI L.Spallanzani"],"award-info":[{"award-number":["to INMI L.Spallanzani"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["IRCCS"],"award-info":[{"award-number":["IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["Fellowship 2017"],"award-info":[{"award-number":["Fellowship 2017"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s15010-019-01313-6","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T05:02:19Z","timestamp":1560142939000},"page":"929-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects"],"prefix":"10.1007","volume":"47","author":[{"given":"Alessandra","family":"Vergori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pinnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaClelia","family":"Brita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Libertone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Mastrorosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ammassari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"1313_CR1","doi-asserted-by":"publisher","first-page":"e1002466","DOI":"10.1371\/journal.pmed.1002466.eCollection","volume":"14","author":"SG Deeks","year":"2017","unstructured":"Deeks SG, Lewin SR. Bekker LG (2017) The end of HIV: still a very long way to go, but progress continues. PLoS Med. 2017;14:e1002466. \nhttps:\/\/doi.org\/10.1371\/journal.pmed.1002466.eCollection\n\n.","journal-title":"PLoS Med"},{"key":"1313_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1683-z","author":"LJ Haddow","year":"2017","unstructured":"Haddow LJ, Laverick R, Daskalopoulou M, Cognitive impairment in people with HIV in the European Region (CIPHER) Study Group, et al. Multicenter European prevalence study of neurocognitive impairment and associated factors in HIV positive patients. AIDS Behav. 2017. \nhttps:\/\/doi.org\/10.1007\/s10461-017-1683-z\n\n.","journal-title":"AIDS Behav"},{"key":"1313_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR Jr, Deutsch R, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60:473\u201380. \nhttps:\/\/doi.org\/10.1093\/cid\/ciu862\n\n(Epub 2014 Oct 31).","journal-title":"Clin Infect Dis"},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s11481-013-9505-1","volume":"8","author":"S Cross","year":"2013","unstructured":"Cross S, \u00d6nen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol. 2013;8:1114\u201322. \nhttps:\/\/doi.org\/10.1007\/s11481-013-9505-1\n\n(Epub 2013 Oct 10).","journal-title":"J Neuroimmune Pharmacol"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fpubh.2014.00105","volume":"2","author":"JM Attonito","year":"2014","unstructured":"Attonito JM, D\u00e9vieux JG, Lerner BD, Hospital MM, Rosenberg R. Exploring substance use and HIV treatment factors associated with neurocognitive impairment among people living with HIV\/AIDS. Front Public Health. 2014;2:105. \nhttps:\/\/doi.org\/10.3389\/fpubh.2014.00105\n\n(eCollection 2014).","journal-title":"Front Public Health"},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087\u201396. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e318200d727\n\n.","journal-title":"Neurology"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/aid.2018.0074","volume":"23","author":"ML Giancola","year":"2018","unstructured":"Giancola ML, Balestra P, Ammassari A, et al. Prevalence and associated factors of neurocognitive impairment in HIV-positive patients on effective efavirenz\/emtricitabine\/tenofovir disoproxil fumarate treatment. AIDS Res Hum Retroviruses. 2018;23:654. \nhttps:\/\/doi.org\/10.1089\/aid.2018.0074\n\n(Epub ahead of print).","journal-title":"AIDS Res Hum Retroviruses."},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3\u201316. \nhttps:\/\/doi.org\/10.1007\/s13365-010-0006-1\n\n(Epub 2010 Dec 21).","journal-title":"J Neurovirol"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1097\/QAD.0000000000001225","volume":"30","author":"BJ Brew","year":"2016","unstructured":"Brew BJ. Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment? AIDS. 2016;30:2379\u201380. \nhttps:\/\/doi.org\/10.1097\/QAD.0000000000001225\n\n.","journal-title":"AIDS"},{"key":"1313_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2147\/cia.s51785","volume":"9","author":"M Schl\u00f6gl","year":"2014","unstructured":"Schl\u00f6gl M, Holick MF. Vitamin D and neurocognitive function. Clin Interv Aging. 2014;9:559\u201368. \nhttps:\/\/doi.org\/10.2147\/cia.s51785\n\n(eCollection 2014).","journal-title":"Clin Interv Aging"},{"key":"1313_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000339702","volume":"33","author":"T Etgen","year":"2012","unstructured":"Etgen T, Sander D, Bickel H, Sander K, F\u00f6rstl H. Vitamin D deficiency cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord. 2012;33:297\u2013305. \nhttps:\/\/doi.org\/10.1159\/000339702\n\n(Epub 2012 Jul 2. Review).","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1313_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.0b013e31826c197f","volume":"79","author":"C Balion","year":"2012","unstructured":"Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition and dementia: a systematic review and metanalysis. Neurology. 2012;79:1397\u2013405.","journal-title":"Neurology"},{"key":"1313_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/gerona\/glq185","volume":"66","author":"DJ Llewellyn","year":"2011","unstructured":"Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly US population. J Gerontol A Biol Sci Med Sci. 2011;66:59\u201365. \nhttps:\/\/doi.org\/10.1093\/gerona\/glq185\n\n(Epub 2010 Nov 1).","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0b013e3181beecb7","volume":"74","author":"JS Buell","year":"2010","unstructured":"Buell JS, Dawson-Hughes B, Scott TM, et al. 25hydroxyvitamin D, dementia and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74:18\u201326. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e3181beecb7\n\n(Epub 2009 Nov 25).","journal-title":"Neurology"},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jalz.2017.03.003","volume":"13","author":"C Feart","year":"2017","unstructured":"Feart C, Helmer C, Merle B, et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer\u2019s disease in older adults. Alzheimers Dement. 2017;13:1207\u201316. \nhttps:\/\/doi.org\/10.1016\/j.jalz.2017.03.003\n\n(Epub 2017 May 16).","journal-title":"Alzheimers Dement"},{"key":"1313_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1684\/pnv.2016.0613","volume":"14","author":"C Annweiler","year":"2016","unstructured":"Annweiler C, Dursun E, F\u00e9ron F, et al. Vitamin D and cognition in older adults: international consensus guidelines. Geriatr Psychol Neuropsychiatr Vieil. 2016;14:265\u201373. \nhttps:\/\/doi.org\/10.1684\/pnv.2016.0613\n\n.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"1313_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.medmal.2018.02.011","volume":"48","author":"L Benguella","year":"2018","unstructured":"Benguella L, Arbault A, Fillion A, et al. Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients. Med Mal Infect. 2018;48:449\u201356. \nhttps:\/\/doi.org\/10.1016\/j.medmal.2018.02.011\n\n(Epub ahead of print).","journal-title":"Med Mal Infect"},{"key":"1313_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/hiv.12563","volume":"19","author":"H Huff","year":"2018","unstructured":"Huff H, Merchant AT, Lonn E, Pullenayegum E, Smaill F, Smieja M. Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians. HIV Med. 2018;19:143\u201351. \nhttps:\/\/doi.org\/10.1111\/hiv.12563\n\n(Epub 2017 Nov 6).","journal-title":"HIV Med"},{"key":"1313_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1089\/AID.2017.0009","volume":"33","author":"A Tin","year":"2017","unstructured":"Tin A, Zhang L, Estrella MM, et al. Vitamin D status and kidney function decline in HIV-infected men: a longitudinal study in the multicenter AIDS cohort study. AIDS Res Hum Retroviruses. 2017;33:1140\u20138. \nhttps:\/\/doi.org\/10.1089\/AID.2017.0009\n\n(Epub 2017).","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-0043-125073","volume":"50","author":"S Noe","year":"2018","unstructured":"Noe S, Oldenbuettel C, Heldwein S, et al. Secondary hyperparathyroidism in HIV-infected patients in Central Europe. Horm Metab Res. 2018;50:317\u201324. \nhttps:\/\/doi.org\/10.1055\/s-0043-125073\n\n(Epub 2018 Jan 23).","journal-title":"Horm Metab Res"},{"key":"1313_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4254\/wjh.v9.i5.278","volume":"9","author":"AS Dadabhai","year":"2017","unstructured":"Dadabhai AS, Saberi B, Lobner K, Shinohara RT, Mullin GE. Influence of vitamin D on liver fibrosis in chronic hepatitis C: a systematic review and meta-analysis of the pooled clinical trials data. World J Hepatol. 2017;9:278\u201387. \nhttps:\/\/doi.org\/10.4254\/wjh.v9.i5.278\n\n.","journal-title":"World J Hepatol"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1055\/s-0036-1593536","volume":"34","author":"J Jao","year":"2017","unstructured":"Jao J, Freimanis L, Mussi-Pinhata MM, NISDI LILAC Protocol, et al. Severe vitamin D deficiency in human immunodeficiency virus-Infected pregnant women is associated with preterm birth. Am J Perinatol. 2017;34:486\u201392. \nhttps:\/\/doi.org\/10.1055\/s-0036-1593536\n\n(Epub 2016 Oct 7).","journal-title":"Am J Perinatol"},{"key":"1313_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fimmu.2018.00458","volume":"9","author":"M\u00c1 Jim\u00e9nez-Sousa","year":"2018","unstructured":"Jim\u00e9nez-Sousa M\u00c1, Mart\u00ednez I, Medrano LM, Fern\u00e1ndez-Rodr\u00edguez A, Resino S. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol. 2018;9:458. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.00458\n\n(eCollection 2018).","journal-title":"Front Immunol"},{"key":"1313_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/nu9070651","volume":"9","author":"PHF Gois","year":"2017","unstructured":"Gois PHF, Ferreira D, Olenski S, Seguro AC. Vitamin D and infectious diseases: simple bystander or contributing factor? Nutrients. 2017;9:651. \nhttps:\/\/doi.org\/10.3390\/nu9070651\n\n.","journal-title":"Nutrients"},{"key":"1313_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12937-015-0072-6","volume":"14","author":"L Coelho","year":"2015","unstructured":"Coelho L, Cardoso SW, Luz PM, et al. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutr J. 2015;14:81.","journal-title":"Nutr J"},{"key":"1313_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc-2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53\u20138. \nhttps:\/\/doi.org\/10.1210\/jc-2010-2704\n\n.","journal-title":"J Clin Endocrinol Metab"},{"key":"1313_CR27","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Endocrine Society, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911\u201330. \nhttps:\/\/doi.org\/10.1210\/jc.2011-0385\n\n.","journal-title":"J Clin Endocrinol Metab"},{"key":"1313_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789\u201399 (Epub 2007 Oct 3).","journal-title":"Neurology"},{"key":"1313_CR29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1017\/S0007114518000491","volume":"119","author":"X Liu","year":"2018","unstructured":"Liu X, Baylin A, Levy PD. Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications. Br J Nutr. 2018;119:928\u201336. \nhttps:\/\/doi.org\/10.1017\/S0007114518000491\n\n.","journal-title":"Br J Nutr"},{"key":"1313_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3851\/IMP2983","volume":"21","author":"KM Klassen","year":"2016","unstructured":"Klassen KM, Fairley CK, Kimlin MG, Hocking J, Kelsall L, Ebeling PR. Vitamin D deficiency is common in HIV-infected southern Australian adults. Antivir Ther. 2016;21:117\u201325. \nhttps:\/\/doi.org\/10.3851\/IMP2983\n\n(Epub 2015 Aug 11).","journal-title":"Antivir Ther"},{"key":"1313_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QAI.0b013e31821ae418","volume":"57","author":"OM Adeyemi","year":"2011","unstructured":"Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr. 2011;57:197\u2013204. \nhttps:\/\/doi.org\/10.1097\/QAI.0b013e31821ae418\n\n.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1313_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JAD-2011-101986","volume":"25","author":"J Yu","year":"2011","unstructured":"Yu J, Gattoni-Celli M, Zhu H, et al. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A\u03b2PP transgenic mice. J Alzheimers Dis. 2011;25:295\u2013307. \nhttps:\/\/doi.org\/10.3233\/JAD-2011-101986\n\n.","journal-title":"J Alzheimers Dis"},{"key":"1313_CR33","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1007\/s12035-017-0839-1","volume":"55","author":"M Morello","year":"2018","unstructured":"Morello M, Landel V, Lacassagne E, et al. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2018;55:6463\u201379. \nhttps:\/\/doi.org\/10.1007\/s12035-017-0839-1\n\n(Epub 2018 Jan 9).","journal-title":"Mol Neurobiol"},{"key":"1313_CR34","doi-asserted-by":"publisher","first-page":"E892","DOI":"10.3390\/ijms19030892","volume":"19","author":"D Caccamo","year":"2018","unstructured":"Caccamo D, Ricca S, Curr\u00f2 M, Ientile R. Health risks of hypovitaminosis D: a review of new molecular insights. Int J Mol Sci. 2018;19:E892. \nhttps:\/\/doi.org\/10.3390\/ijms19030892\n\n.","journal-title":"Int J Mol Sci"},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","volume":"13","author":"E Garcion","year":"2002","unstructured":"Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100\u20135.","journal-title":"Trends Endocrinol Metab"},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.metabol.2011.09.007","volume":"61","author":"A Vaidya","year":"2012","unstructured":"Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease and diabetes. Metabolism. 2012;61:450\u20138. \nhttps:\/\/doi.org\/10.1016\/j.metabol.2011.09.007\n\n(Epub 2011 Nov 9).","journal-title":"Metabolism"},{"key":"1313_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/cid\/ciq239","volume":"52","author":"AI Choi","year":"2011","unstructured":"Choi AI, Lo JC, Mulligan K, et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV infected persons. Clin Infect Dis. 2011;52:941\u20134.","journal-title":"Clin Infect Dis"},{"key":"1313_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1212\/WNL.0b013e3182478d64","volume":"78","author":"JA McCutchan","year":"2012","unstructured":"McCutchan JA, Marquie-Beck JA, Fitzsimons CA, CHARTER group, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012;78:485\u201392.","journal-title":"Neurology"},{"key":"1313_CR39","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1212\/WNL.0000000000001815","volume":"85","author":"C Dufouil","year":"2015","unstructured":"Dufouil C, Richert L, Thi\u00e9baut R, ANRS CO3 Aquitaine Study Group, et al. Diabetes and cognitive decline in a French cohort of patients infected with HIV-1. Neurology. 2015;85:1065\u201373.","journal-title":"Neurology"},{"key":"1313_CR40","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/bcp.13652","volume":"84","author":"CT Sempos","year":"2018","unstructured":"Sempos CT, Heijboer AC, Bikle DD. Vitamin D assays and the definition of hypovitaminosis D: results from the 1st international conference on controversies in vitamin D. Br J Clin Pharmacol. 2018;84:2194\u2013207. \nhttps:\/\/doi.org\/10.1111\/bcp.13652\n\n(Epub ahead of print).","journal-title":"Br J Clin Pharmacol"},{"key":"1313_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11904-018-0401-4","volume":"15","author":"E Hsieh","year":"2018","unstructured":"Hsieh E, Yin MT. Continued interest and controversy: vitamin D in HIV. Curr HIV\/AIDS Rep. 2018;15:199\u2013211. \nhttps:\/\/doi.org\/10.1007\/s11904-018-0401-4\n\n.","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-019-01313-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:14:32Z","timestamp":1591658072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-019-01313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s15010-019-01313-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Adriana Ammassari (AAm) received speaker\u2019s fees from AbbVie, BMS, Gilead, Janssen Cilag, Merck, ViiV and participated in Advisory Boards for Merck and Janssen; Andrea Antinori (AAn) received personal fees for consultancy and lectures from AbbVie, Bristol Myers Squibb, Gilead, Janssen, Merck, ViiV and research institutional grants from Bristol Myers Squibb, Gilead, Janssen, ViiV. Carmela Pinnetti (CP) participated in Advisory Boards for Janssen and received speaker\u2019s fees from Gilead. For the remaining authors, none were declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}